Vinod Balasa

655 total citations
22 papers, 467 citations indexed

About

Vinod Balasa is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Vinod Balasa has authored 22 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 9 papers in Genetics and 6 papers in Rheumatology. Recurrent topics in Vinod Balasa's work include Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Vinod Balasa is often cited by papers focused on Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Vinod Balasa collaborates with scholars based in United States, Canada and Japan. Vinod Balasa's co-authors include Ralph A. Gruppo, Charles J. Glueck, Davis Stroop, Ann De Becker, Ping Wang, Michael Wang, Marilyn J. Manco‐Johnson, Taru Hays, Leonard A. Valentino and Karen Kalinyak and has published in prestigious journals such as Blood, Journal of Bone and Joint Surgery and The Journal of Pediatrics.

In The Last Decade

Vinod Balasa

22 papers receiving 444 citations

Peers

Vinod Balasa

HEMAT

GENET

SURGE

CCM

Anthea Greenway Australia

Ramzi El Accaoui United States

H. Vielhaber Germany

J. W. Laws United Kingdom

L. Scarano Italy

N. Münchow Germany

Elisabetta Favaretto Italy

Alberta Scudeller Italy

Geoffrey Kershaw Australia

Deborah L. Manjoney United States

Anthea Greenway Australia

Vinod Balasa

137 ×0.4

HEMAT

47 ×0.4

GENET

45 ×0.4

SURGE

47 ×0.4

63 ×0.8

CCM

Citations per year, relative to Vinod Balasa Vinod Balasa (= 1×) peers Anthea Greenway

Countries citing papers authored by Vinod Balasa

Since Specialization

Citations

This map shows the geographic impact of Vinod Balasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinod Balasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinod Balasa more than expected).

Fields of papers citing papers by Vinod Balasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinod Balasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinod Balasa. The network helps show where Vinod Balasa may publish in the future.

Co-authorship network of co-authors of Vinod Balasa

This figure shows the co-authorship network connecting the top 25 collaborators of Vinod Balasa. A scholar is included among the top collaborators of Vinod Balasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinod Balasa. Vinod Balasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Young, Guy, Michael U. Callaghan, Vinod Balasa, et al.. (2023). Effects of PK‐guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A. Haemophilia. 29(5). 1234–1242. 1 indexed citations

Sun, Shawn X., et al.. (2022). Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A. Expert Review of Hematology. 15(10). 943–950. 6 indexed citations

Calderwood, Stanley, et al.. (2022). SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature. Journal of Pediatric Hematology/Oncology. 45(2). 82–87. 1 indexed citations

Yoshida, Yilin, Michael R. Weaver, Lila S. Nolan, et al.. (2021). Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study. Acta Haematologica. 145(2). 160–169. 3 indexed citations

Graf, Lukas, Songkai Yan, Ming‐Ching Shen, & Vinod Balasa. (2020). A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A. Journal of Medical Economics. 23(12). 1493–1498. 6 indexed citations

Chelle, Pierre, Cindy H. T. Yeung, Stacy E. Croteau, et al.. (2019). Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup. Clinical Pharmacokinetics. 59(2). 245–256. 18 indexed citations

Yoshida, Yilin, et al.. (2019). Unusually High Prevalence of Silent Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease. Blood. 134(Supplement_1). 2276–2276. 2 indexed citations

Lal, Ashutosh, Trisha E. Wong, Jennifer Andrews, et al.. (2018). Transfusion practices and complications in thalassemia. Transfusion. 58(12). 2826–2835. 23 indexed citations

Fung, Ellen B., Paul Harmatz, Meredith Milet, et al.. (2008). Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Transfusion. 48(9). 1971–1980. 28 indexed citations

10.

Balasa, Vinod. (2005). New anticoagulants: A pediatric perspective. Pediatric Blood & Cancer. 45(6). 741–752. 8 indexed citations

11.

Balasa, Vinod, Ralph A. Gruppo, Charles J. Glueck, et al.. (2004). LEGG-CALVÉ-PERTHES DISEASE AND THROMBOPHILIA. Journal of Bone and Joint Surgery. 86(12). 2642–2647. 78 indexed citations

12.

Balasa, Vinod, Ralph A. Gruppo, Charles J. Glueck, et al.. (2004). Legg-Calve-Perthes Disease and Thrombophilia. Journal of Investigative Medicine. 52(2_suppl_part_1). 349–349. 1 indexed citations

13.

Wang, Michael, Taru Hays, Vinod Balasa, et al.. (2003). Low-Dose Tissue Plasminogen Activator Thrombolysis in Children. Journal of Pediatric Hematology/Oncology. 25(5). 379–386. 100 indexed citations

14.

Balasa, Vinod, Karen Kalinyak, Judy A. Bean, Davis Stroop, & Ralph A. Gruppo. (2002). Hyperhomocysteinemia Is Associated With Low Plasma Pyridoxine Levels in Children With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology. 24(5). 374–379. 24 indexed citations

15.

Gruppo, Ralph A., et al.. (2000). Protein C deficiency related to valproic acid therapy: A possible association with childhood stroke. The Journal of Pediatrics. 137(5). 714–718. 12 indexed citations

16.

Balasa, Vinod, Ralph A. Gruppo, Peter S. Gartside, & Karen Kalinyak. (1999). Correlation of the C677T MTHFR Genotype With Homocysteine Levels in Children With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology. 21(5). 397–400. 24 indexed citations

17.

Balasa, Vinod, Charles J. Glueck, Davis Stroop, et al.. (1999). The Relationship of Mutations in the MTHFR, Prothrombin, and PAI-1 Genes to Plasma Levels of Homocysteine, Prothrombin, and PAI-1 in Children and Adults. Thrombosis and Haemostasis. 81(5). 739–744. 102 indexed citations

18.

Balasa, Vinod, Ralph A. Gruppo, & Han‐Mou Tsai. (1999). #467 Familial chronic thrombotic thrombocytopenic purpura (TTP) due to vWF-cleaving metalloproteinase deficiency in 2 families. Journal of Pediatric Hematology/Oncology. 21(4). 332–332. 2 indexed citations

19.

Balasa, Vinod, et al.. (1998). #512 Mutations in the methylenetetrahydrofolate reductase, prothrombin and plasminogen activator inhibitor-1 genes and homocysteine, prothrombin, and plasminogen activator inhibitor-1 levels in 197 healthy children and 40 healthy adults. Journal of Pediatric Hematology/Oncology. 20(4). 370–370. 1 indexed citations

20.

Balasa, Vinod, et al.. (1998). #511 Pediatric stroke and thrombophilia. Journal of Pediatric Hematology/Oncology. 20(4). 370–370. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact